Li Jun, Armon Carl, Palella Frank J, Tedaldi Ellen, Novak Richard M, Fuhrer Jack, Simoncini Gina, Carlson Kimberly, Buchacz Kate
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cerner Corporation, Kansas City, Missouri, USA.
Open Forum Infect Dis. 2021 Apr 17;8(4):ofaa645. doi: 10.1093/ofid/ofaa645. eCollection 2021 Apr.
National guidelines recommend that sexually active people with human immunodeficiency virus (PWH) who are men who have sex with men (MSM) be tested for hepatitis C virus (HCV) infection at least annually. Hepatitis C virus testing rates vary by race/ethnicity in the general population, but limited data are available for PWH.
We analyzed medical records data from MSM in the HIV Outpatient Study at 9 human immunodeficiency virus (HIV) clinics from January 1, 2011 through December 31, 2019. We excluded observation time after documented past or current HCV infection. We evaluated HCV antibody testing in each calendar year among HCV-seronegative MSM, and we assessed testing correlates by generalized estimating equation analyses.
Of 1829 eligible MSM who were PWH, 1174 (64.2%) were non-Hispanic/Latino white (NHW), 402 (22.0%) non-Hispanic black (NHB), 187 (10.2%) Hispanic/Latino, and 66 (3.6%) of other race/ethnicity. Most were ≥40 years old (68.9%), privately insured (64.5%), with CD4 cell count/mm (CD4) ≥350 (77.0%), and with HIV viral load <200 copies/mL (76.9%). During 2011-2019, 1205 (65.9%) had ≥1 HCV antibody test and average annual HCV percentage tested was 30.3% (from 33.8% for NHB to 28.5% for NHW; < .001). Multivariable factors positively associated ( < .05) with HCV testing included more recent HIV diagnosis, public insurance, lower CD4, prior chlamydia, gonorrhea, syphilis, or hepatitis B virus diagnoses, and elevated liver enzyme levels, but not race/ethnicity.
Although we found no disparities by race/ethnicity in HCV testing, low overall HCV testing rates indicate suboptimal uptake of recommended HCV testing among MSM in HIV care.
国家指南建议,男男性行为者(MSM)中的人类免疫缺陷病毒(HIV)感染者(PWH),如有性行为,应至少每年进行丙型肝炎病毒(HCV)感染检测。在普通人群中,丙型肝炎病毒检测率因种族/族裔而异,但关于PWH的数据有限。
我们分析了2011年1月1日至2019年12月31日期间,9家人类免疫缺陷病毒(HIV)诊所的HIV门诊研究中MSM的病历数据。我们排除了记录有既往或当前HCV感染后的观察时间。我们评估了HCV血清阴性MSM在每个日历年的HCV抗体检测情况,并通过广义估计方程分析评估检测的相关因素。
在1829名符合条件的PWH MSM中,1174名(64.2%)为非西班牙裔/拉丁裔白人(NHW),402名(22.0%)为非西班牙裔黑人(NHB),187名(10.2%)为西班牙裔/拉丁裔,66名(3.6%)为其他种族/族裔。大多数人年龄≥40岁(68.9%),有私人保险(64.5%),CD4细胞计数/mm(CD4)≥350(77.0%),HIV病毒载量<200拷贝/mL(76.9%)。在2011 - 2019年期间,1205名(65.9%)进行了≥1次HCV抗体检测,年均HCV检测百分比为30.3%(从NHB的33.8%到NHW的28.5%;P<0.001)。与HCV检测呈正相关(P<0.05)的多变量因素包括最近的HIV诊断、公共保险、较低的CD4、既往衣原体、淋病、梅毒或乙型肝炎病毒诊断以及肝酶水平升高,但不包括种族/族裔。
虽然我们发现HCV检测在种族/族裔方面没有差异,但总体HCV检测率较低表明,在接受HIV治疗的MSM中,推荐的HCV检测的接受程度不理想。